Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Goldgar DE"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Autorzy:
Kuchenbaecker KB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Tyrer J; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Lee A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Shen HC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Beesley J; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Lawrenson K; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Healey S; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Lee JM; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Spindler TJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Lin YG; Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California, USA.
Pejovic T; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
Bean Y; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
Li Q; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Coetzee S; 1] Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. [2] Center for Cell-Based Therapy, Monte Alegre, Ribeirão Preto, Brazil. [3] Center for Integrative Systems Biology, Monte Alegre, Ribeirão Preto, Brazil.
Hazelett D; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Urology, University of Southern California, Los Angeles, California, USA.
Miron A; Department of Genomics and Genome Sciences, Case Western Reserve University Medical School, Cleveland, Ohio, USA.
Southey M; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
Terry MB; Department of Epidemiology, Columbia University, New York, New York, USA.
Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Buys SS; Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Janavicius R; 1] Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medical Center, Vilinius University Hospital Santariskiu Clinics, Vilnius, Lithuania, Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania. [2] State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Dorfling CM; Department of Genetics, University of Pretoria, Pretoria, South Africa.
van Rensburg EJ; Department of Genetics, University of Pretoria, Pretoria, South Africa.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Jønson L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Dennis J; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [2] Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Benitez J; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Human Genotyping Unit (CEGEN), Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [3] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Osorio A; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Garcia MJ; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Komenaka I; Maricopa Medical Center, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
Weitzel JN; Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
Ganschow P; Cook County Health and Hospital System, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
Peterlongo P; Fondazione Istituto FIRC (Italian Foundation for Cancer Research) di Oncologia Molecolare (IFOM), Milan, Italy.
Bernard L; 1] Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy. [2] Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Viel A; Division of Experimental Oncology, CRO (Centro di Riferimento Oncologico) Aviano National Cancer Institute, Aviano, Italy.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico (Italian Research Hospital)) Istituto Nazionale Tumori (INT), Milan, Italy.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico (Italian Research Hospital)) Istituto Nazionale Tumori (INT), Milan, Italy.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Papi L; Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
Ottini L; Department of Molecular Medicine, University La Sapienza, Rome, Italy.
Fostira F; Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Perkins J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Platte R; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Ellis S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Schmutzler RK; 1] Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany. [2] Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany. [3] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. [4] On behalf of the German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC).
Meindl A; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
Sutter C; Institute of Human Genetics, University Heidelberg, Heidelberg, Germany.
Sinilnikova OM; 1] INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France. [2] Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France.
Damiola F; INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Mazoyer S; INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Stoppa-Lyonnet D; 1] Institut Curie, Department of Tumour Biology, Paris, France. [2] Institut Curie, INSERM U830, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Claes K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
De Leeneer K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Kirk J; Australia New Zealand Gynecologic Oncology Group (ANZGOG) and Familial Cancer Service, Westmead Hosptial, Sydney, New South Wales, Australia.
Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Piedmonte M; Gynecologic Oncology Group, Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, USA.
O'Malley DM; James Cancer Center, Ohio State University, Columbus, Ohio, USA.
de la Hoya M; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Collée JM; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands.
Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Oosterwijk JC; Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands.
Tihomirova L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Hamann U; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Isaccs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Tischkowitz M; Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada.
Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
Caligo MA; Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy.
Campbell IG; VBCRC (Victorian Breast Cancer Research Consortium) Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Diez O; Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, Spain.
Blanco I; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute)-Catalan Institute of Oncology, Barcelona, Spain.
Brunet J; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona)-Catalan Institute of Oncology, Girona, Spain.
Lazaro C; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
Pujana MA; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Sukiennicki G; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Barkardottir RB; Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Plante M; Gynaecologic Oncology Service, Centre Hospitalier Universitaire de Québec (CHUQ), Quebec City, Quebec, Canada.
Simard J; Centre Hospitalier Universitaire de Québec (CHUQ) Research Center, Laval University, Quebec City, Quebec, Canada.
Soucy P; Centre Hospitalier Universitaire de Québec (CHUQ) Research Center, Laval University, Quebec City, Quebec, Canada.
Montagna M; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy.
Tognazzo S; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy.
Teixeira MR; 1] Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. [2] Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Pankratz VS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Lindor N; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Szabo CI; National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA.
Kauff N; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Vijai J; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Aghajanian CA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Pfeiler G; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Berger A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Tea MK; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
Mai PL; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
Rennert G; Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
Mulligan AM; 1] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. [2] Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Tchatchou S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Andrulis IL; 1] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, Ohio, USA.
Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Bojesen A; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
Zidan J; Institute of Oncology, Rivka Ziv Medical Center, Zefat, Israel.
Friedman E; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Aviv, Israel.
Laitman Y; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Aviv, Israel.
Soller M; Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
Liljegren A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Arver B; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Einbeigi Z; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Stenmark-Askmalm M; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Olopade OI; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, USA.
Nussbaum RL; Department of Medicine and Genetics, University of California, San Francisco, San Francisco, California, USA.
Rebbeck TR; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Nathanson KL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Domchek SM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lu KH; Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Hein A; Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany.
Ekici AB; Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
Beckmann MW; Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany.
Fasching PA; 1] Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany. [2] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Lambrechts D; 1] Vesalius Research Center, VIB, Leuven, Belgium. [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Van Nieuwenhuysen E; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
Vergote I; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
Lambrechts S; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
Dicks E; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Doherty JA; Department of Community and Family Medicine, Section of Biostatistics and Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Wicklund KG; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Rossing MA; 1] Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Wang-Gohrke S; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
Eilber U; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Sucheston L; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
Lele S; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Goodman MT; 1] Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. [2] Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Thompson PJ; 1] Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. [2] Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Shvetsov YB; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Runnebaum IB; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
Dürst M; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
Hillemanns P; Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Antonenkova N; Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus.
Bogdanova N; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Leminen A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Pelttari LM; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Butzow R; 1] Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. [2] Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland.
Modugno F; 1] Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [2] Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. [3] Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [4] Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
Kelley JL; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Edwards RP; 1] Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. [2] Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Ness RB; University of Texas School of Public Health, Houston, Texas, USA.
du Bois A; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Heitz F; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Schwaab I; Institut für Humangenetik Wiesbaden, Wiesbaden, Germany.
Harter P; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Matsuo K; Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
Hosono S; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Kjaer SK; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. [2] Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Hogdall E; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. [2] Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
Hasmad HN; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia.
Azmi MA; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Teo SH; 1] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. [2] University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Woo YL; 1] Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia. [2] University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Fridley BL; Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas, USA.
Goode EL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Vierkant RA; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
Bruinsma F; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
Liang D; College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA.
Hildebrandt MA; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wu X; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
Iversen ES; Department of Statistical Science, Duke University, Durham, North Carolina, USA.
Schildkraut JM; 1] Cancer Control and Population Sciences, Duke Cancer Institute, Durham, North Carolina, USA. [2] Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Concannon P; 1] Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA. [2] Genetics Institute, University of Florida, Gainesville, Florida, USA.
Weber RP; Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Cramer DW; 1] Harvard School of Public Health, Boston, Massachusetts, USA. [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Terry KL; 1] Harvard School of Public Health, Boston, Massachusetts, USA. [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Poole EM; 1] Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Tworoger SS; 1] Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Bandera EV; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Orlow I; Department of Epidemiology and Biostatistics, Epidemiology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Olson SH; Department of Epidemiology and Biostatistics, Epidemiology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Krakstad C; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Salvesen HB; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Tangen IL; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Bjorge L; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
van Altena AM; Department of Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Aben KK; 1] Comprehensive Cancer Center The Netherlands, Utrecht, the Netherlands. [2] Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands.
Kiemeney LA; 1] Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands. [2] Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Massuger LF; Department of Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Kellar M; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
Brooks-Wilson A; 1] Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. [2] Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
Kelemen LE; Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Cook LS; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
Le ND; Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Clinic of Opthalmology, Pomeranian Medical University, Szczecin, Poland.
Yang H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Lissowska J; Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Hogdall C; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Lundvall L; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Nedergaard L; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Baker H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Song H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Eccles D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
McNeish I; Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, UK.
Paul J; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Carty K; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK.
Glasspool R; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Whittemore AS; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
Rothstein JH; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
McGuire V; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
Sieh W; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
Ji BT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Zheng W; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Shu XO; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Gao YT; Shanghai Cancer Institute, Shanghai, China.
Rosen B; 1] Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. [2] Department of Gynecologic-Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
McLaughlin JR; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Narod SA; Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Monteiro AN; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Chen A; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
Lin HY; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
Permuth-Wey J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Tsai YY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Chen Z; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
Ziogas A; Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
Anton-Culver H; Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
Gentry-Maharaj A; Women's Cancer, University College London Elizabeth Garrett Anderson (EGA) Institute for Women's Health, London, UK.
Menon U; Women's Cancer, University College London Elizabeth Garrett Anderson (EGA) Institute for Women's Health, London, UK.
Harrington P; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Lee AW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Pearce CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Coetzee G; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Urology, University of Southern California, Los Angeles, California, USA.
Pike MC; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Dansonka-Mieszkowska A; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Timorek A; Department of Obstetrics, Gynecology and Oncology, 2nd Faculty of Medicine, Warsaw Medical University and Brodnowski Hospital, Warsaw, Poland.
Rzepecka IK; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Kupryjanczyk J; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Freedman M; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Noushmehr H; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Offit K; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Couch FJ; 1] Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. [2] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Gayther S; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Pharoah PP; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Chenevix-Trench G; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Pokaż więcej
Corporate Authors:
EMBRACE
GEMO Study Collaborators
Breast Cancer Family Registry
HEBON
KConFab Investigators
Australian Cancer Study (Ovarian Cancer Investigators)
Australian Ovarian Cancer Study Group
Consortium of Investigators of Modifiers of BRCA1 and BRCA2
Źródło:
Nature genetics [Nat Genet] 2015 Feb; Vol. 47 (2), pp. 164-71. Date of Electronic Publication: 2015 Jan 12.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease*
Polymorphism, Single Nucleotide*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Genome-Wide Association Study/*methods
Neoplasms, Glandular and Epithelial/*genetics
Ovarian Neoplasms/*genetics
Adolescent ; Adult ; Alleles ; Carcinoma, Ovarian Epithelial ; Female ; Genes, Reporter ; Genotype ; Heterozygote ; Humans ; Mutation ; Quantitative Trait Loci ; Risk ; Young Adult
Czasopismo naukowe
Tytuł:
Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation.
Autorzy:
Whiley PJ; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia ; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
Parsons MT; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Leary J; Familial Cancer Service, Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, NSW, Australia.
Tucker K; Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia.
Warwick L; Genetics Department, The Canberra Hospital, Canberra, ACT, Australia.
Dopita B; Genetics Department, The Canberra Hospital, Canberra, ACT, Australia.
Thorne H; kConFab, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Lakhani SR; The University of Queensland, UQ Centre for Clinical Research and School of Medicine, and Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Goldgar DE; Huntsman Cancer Institute and Department of Dermatology, University of Utah, Salt Lake City, Utah, United States of America.
Brown MA; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
Spurdle AB; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Jan 28; Vol. 9 (1), pp. e86836. Date of Electronic Publication: 2014 Jan 28 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Genetic Predisposition to Disease*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Multifactorial Inheritance/*genetics
Mutation, Missense/*genetics
Alternative Splicing/genetics ; Computational Biology ; Exons/genetics ; Humans ; Likelihood Functions ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Reproducibility of Results ; Sequence Deletion/genetics
Czasopismo naukowe
Tytuł:
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
Autorzy:
Gaudet MM; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Kuchenbaecker KB
Vijai J
Klein RJ
Kirchhoff T
McGuffog L
Barrowdale D
Dunning AM
Lee A
Dennis J
Healey S
Dicks E
Soucy P
Sinilnikova OM
Pankratz VS
Wang X
Eldridge RC
Tessier DC
Vincent D
Bacot F
Hogervorst FB
Peock S
Stoppa-Lyonnet D
Peterlongo P
Schmutzler RK
Nathanson KL
Piedmonte M
Singer CF
Thomassen M
Hansen Tv
Neuhausen SL
Blanco I
Greene MH
Garber J
Weitzel JN
Andrulis IL
Goldgar DE
D'Andrea E
Caldes T
Nevanlinna H
Osorio A
van Rensburg EJ
Arason A
Rennert G
van den Ouweland AM
van der Hout AH
Kets CM
Aalfs CM
Wijnen JT
Ausems MG
Frost D
Ellis S
Fineberg E
Platte R
Evans DG
Jacobs C
Adlard J
Tischkowitz M
Porteous ME
Damiola F
Golmard L
Barjhoux L
Longy M
Belotti M
Ferrer SF
Mazoyer S
Spurdle AB
Manoukian S
Barile M
Genuardi M
Arnold N
Meindl A
Sutter C
Wappenschmidt B
Domchek SM
Pfeiler G
Friedman E
Jensen UB
Robson M
Shah S
Lazaro C
Mai PL
Benitez J
Southey MC
Schmidt MK
Fasching PA
Peto J
Humphreys MK
Wang Q
Michailidou K
Sawyer EJ
Burwinkel B
Guénel P
Bojesen SE
Milne RL
Brenner H
Lochmann M
Aittomäki K
Dörk T
Margolin S
Mannermaa A
Lambrechts D
Chang-Claude J
Radice P
Giles GG
Haiman CA
Winqvist R
Devillee P
García-Closas M
Schoof N
Hooning MJ
Cox A
Pharoah PD
Jakubowska A
Orr N
González-Neira A
Pita G
Alonso MR
Hall P
Couch FJ
Simard J
Altshuler D
Easton DF
Chenevix-Trench G
Antoniou AC
Offit K
Pokaż więcej
Corporate Authors:
KConFab Investigators
Ontario Cancer Genetics Network
HEBON
EMBRACE
GEMO Study Collaborators
GENICA Network
Źródło:
PLoS genetics [PLoS Genet] 2013; Vol. 9 (3), pp. e1003173. Date of Electronic Publication: 2013 Mar 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Genome-Wide Association Study*
BRCA2 Protein/*genetics
Breast Neoplasms/*genetics
Chromosomes, Human, Pair 6/*genetics
Adult ; Aged ; Alleles ; BRCA1 Protein/genetics ; Breast Neoplasms/pathology ; Female ; Genetic Predisposition to Disease ; Genotype ; Heterozygote ; Humans ; Middle Aged ; Mutation ; Polymorphism, Single Nucleotide ; Risk Factors
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies